Search
Protocol No.: MK7655A-021
- Title
- A Phase 2/3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of MK-7655A in Pediatric Participants From Birth to Less Than 18 Years of Age With Confirmed or Suspected Gram-negative Bacterial Infection
- Principal Investigator
- Lancaster, Jeffrey
- Phase
- II/III
- Age Group
- Children
- Applicable Disease Site
- Pediatrics
- Participating Institution
- Health Sciences Center
- Contact
- Jessica Tissue, RRT
- Clinical Research Coordinator
- Phone: +1 724-984-8707
- Email: jessica.tissue1@hsc.wvu.edu